A pilot study of pharmacogenomic testing as a tool to enhance depression care in Veterans
{{output}}
Modest outcomes from pharmacogenomic (PGx) testing in depression may be influenced by low rates of actionable gene-drug interactions. This 12-week pilot pragmatic randomized clinical trial evaluated the effectiveness of selectively targeting PGx testing to dep... ...
